Avastin cancer drug may cause brain bleeding, warns FDA

Email this article to a friend

Printable Version

Articles Related to This Article: • Anti-Cancer Drug Avastin Useless Against Breast Cancer, Declares FDA • FDA Approves Breast Cancer Drug Avastin Despite Opposition by Advisory Panel • Genentech sets price gouging limit for Avastin cancer drug Support NaturalNews advertisers - Advertise with NaturalNews Help support NaturalNews with health books and educational programs from Truth Publishing: • Swine Flu Advanced Preparedness • 8 Weeks to Vibrant Health • Raw In Ten Minutes (recipes) • How to Halt Diabetes in 25 Days ... and much more.

(NaturalNews) Genentech's cancer-fighting drug Avastin's label now includes warnings related to a rare brain-bleeding condition and deterioration of nasal tissue that both have been associated with the drug. The FDA's website now notes that Avastin can possibly cause a rare brain-capillary leak syndrome that can lead to headaches, seizure, blindness and other visual and neurological problems.

Genentech countered with its own statistics, saying that less than 0.1 percent of the 60,000 patients treated with Avastin have reported these related conditions, and in addition, that the conditions are reversible. The side effect includes small holes that develop between the cartilage separating the two nostrils that result in nasal discharge and bleeding.

Genentech was not actively pursuing possible visual and neurological problems related to its Avastin drug until some letters to the New England Journal of Medicine were published in the March 2006 issue. In addition, the Food and Drug Administration wants more information before it decides whether to approve Avastin as a cancer-treatment drug, which will probably delay final FDA action until late 2007.

Genentech has indicated to stockholders that FDA approval for new uses of Avastin would help boost the drug's profit margin by about two-thirds -- as much as $90,000 per patient annually -- due to the fact that some uses of the drug, like breast cancer treatment, require twice as much product to be used compared to colorectal cancer treatments.

Genentech's Avastin generated $1.1 billion in revenue in 2005 and is currently used with traditional chemotherapy treatments to treat colorectal cancer. In addition to the previously noted side effects, Genentech says that other side effects of Avastin include nosebleeds, high blood pressure, too much protein in the urine, weakness, pain, diarrhea and reduced white blood-cell count.

###

Share

Get articles like this delivered to you FREE in our popular email newsletter

Related CounterThink Cartoons:

Related Articles: • Anti-Cancer Drug Avastin Useless Against Breast Cancer, Declares FDA • FDA Approves Breast Cancer Drug Avastin Despite Opposition by Advisory Panel • Genentech sets price gouging limit for Avastin cancer drug	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/020558_avastin_Genentech_cancer.html Reprinting this article: Non-commercial use OK, cite NaturalNews.com with clickable link. Embed article link: (copy HTML code below): <a href = "http://www.NaturalNews.com/020558_avastin_Genentech_cancer.html">Avastin cancer drug may cause brain bleeding, warns FDA</a>